Scorpion Therapeutics reported raising $126 Million in an initial SEC Form D filing, from an offering of $150 Million
PRIVATEJul 16, 2024$125.7M of $150M raised
Amount Raised
$126 Million
$126 Million sold, per SEC Form D (first sale Jul 1, 2024)
Round Type
Venture
BostonBiotechnologyHealth CareMedicalTherapeutics
Quick answer
Scorpion Therapeutics raised $126 Million in a funding round, dated July 1, 2024. Scorpion Therapeutics is based in Boston, Massachusetts, United States.
How much did Scorpion Therapeutics raise?
Scorpion Therapeutics raised $126 Million in a funding round on July 1, 2024.
What does Scorpion Therapeutics do?
Scorpion is a pioneering clinical-stage oncology company redefining the frontier of precision medicine to deliver optimized and transformational therapies for larger populations of patients with cancer, a strategy..
Where is Scorpion Therapeutics based and how big is it?
Scorpion Therapeutics is based in Boston, Massachusetts, United States.
Who are the decision-makers at Scorpion Therapeutics?
Fundz holds 1 contact at Scorpion Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Scorpion Therapeutics, and when
A new round usually means Scorpion Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Scorpion Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Scorpion Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Scorpion Therapeutics. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Scorpion Therapeutics
Location
Boston, Massachusetts, United States
About
Scorpion is a pioneering clinical-stage oncology company redefining the frontier of precision medicine to deliver optimized and transformational therapies for larger populations of patients with cancer, a strategy Scorpion refers to as Precision Oncology 2.0. Scorpion has built a proprietary and fully integrated platform of the most advanced technologies across cancer biology, medicinal chemistry, and data sciences, with the goal of consistently and rapidly creating exquisitely selective small molecule compounds against an unprecedented spectrum of targets. Scorpion aims to leverage its platform to advance a broad pipeline of wholly owned, optimized compounds across three target categories: best-in-class molecules targeting validated oncogene targets; first-in-class molecules for previously undruggable targets; and first-in-class molecules for novel cancer targets. For more information, visit www.scorpiontx.com.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Scorpion Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
BostonBiotechnologyHealth CareMedicalTherapeutics